Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model

Lisa P. Abramson, Veronica Stellmach, Jennifer A. Doll, Mona Cornwell, Robert M. Arensman, Susan E. Crawford, Henri Ford

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Background/Purpose: Pigment epithelium-derived factor (PEDF), a potent endogenous inhibitor of angiogenesis, is highly expressed in the kidney. The authors postulated that systemic administration of PEDF would decrease Wilms' tumor growth in a xenograft model, and increased renal vascularity would result in a mouse null for PEDF. Methods: Tumors were induced in athymic mice using human anaplastic Wilms' tumor cells. Purified PEDF protein or vehicle was administered for 7 days beginning 2 to 3 weeks after inoculation. Tumors were stained with anti-PEDF and anti-Factor VIII antibodies. Mitoses and microvascular density (MVD) were counted per high-power field (hpf). PEDF-null mice were generated on a SV129/C57BI6 background. Wild-type and null kidneys were assessed for MVD. Results: Mean tumor weight in the 2-week group was 60% less than controls (P < .05). The MVD and mitotic count in treated tumors were significantly less than controls (P < .05). PEDF stained strongly in normal kidneys but was minimal to absent in Wilms' tumor. PEDF-null kidneys had increased MVD compared with wild-type (P < .05). Conclusions: PEDF is expressed strongly in normal murine kidney, and loss of its angioinhibitory activity may contribute to pathologic angiogenesis in Wilms' tumor. Systemic PEDF suppresses WT growth by targeting both the tumor cells and its associated vasculature.

Original languageEnglish (US)
Pages (from-to)336-342
Number of pages7
JournalJournal of Pediatric Surgery
Volume38
Issue number3
DOIs
StatePublished - Mar 1 2003
Externally publishedYes

Fingerprint

Wilms Tumor
Heterografts
Growth
Kidney
Neoplasms
pigment epithelium-derived factor
Pathologic Neovascularization
Angiogenesis Inhibitors
Factor VIII
Tumor Burden
Mitosis
Nude Mice

Keywords

  • Anaplasia
  • Angiogenesis inhibitors
  • Pigment epithelium-derived factor
  • Wilms' tumor
  • Xenograft

ASJC Scopus subject areas

  • Surgery
  • Pediatrics, Perinatology, and Child Health

Cite this

Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model. / Abramson, Lisa P.; Stellmach, Veronica; Doll, Jennifer A.; Cornwell, Mona; Arensman, Robert M.; Crawford, Susan E.; Ford, Henri.

In: Journal of Pediatric Surgery, Vol. 38, No. 3, 01.03.2003, p. 336-342.

Research output: Contribution to journalArticle

Abramson, Lisa P. ; Stellmach, Veronica ; Doll, Jennifer A. ; Cornwell, Mona ; Arensman, Robert M. ; Crawford, Susan E. ; Ford, Henri. / Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model. In: Journal of Pediatric Surgery. 2003 ; Vol. 38, No. 3. pp. 336-342.
@article{3f653e9f5849497f8aa57520559fe26c,
title = "Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model",
abstract = "Background/Purpose: Pigment epithelium-derived factor (PEDF), a potent endogenous inhibitor of angiogenesis, is highly expressed in the kidney. The authors postulated that systemic administration of PEDF would decrease Wilms' tumor growth in a xenograft model, and increased renal vascularity would result in a mouse null for PEDF. Methods: Tumors were induced in athymic mice using human anaplastic Wilms' tumor cells. Purified PEDF protein or vehicle was administered for 7 days beginning 2 to 3 weeks after inoculation. Tumors were stained with anti-PEDF and anti-Factor VIII antibodies. Mitoses and microvascular density (MVD) were counted per high-power field (hpf). PEDF-null mice were generated on a SV129/C57BI6 background. Wild-type and null kidneys were assessed for MVD. Results: Mean tumor weight in the 2-week group was 60{\%} less than controls (P < .05). The MVD and mitotic count in treated tumors were significantly less than controls (P < .05). PEDF stained strongly in normal kidneys but was minimal to absent in Wilms' tumor. PEDF-null kidneys had increased MVD compared with wild-type (P < .05). Conclusions: PEDF is expressed strongly in normal murine kidney, and loss of its angioinhibitory activity may contribute to pathologic angiogenesis in Wilms' tumor. Systemic PEDF suppresses WT growth by targeting both the tumor cells and its associated vasculature.",
keywords = "Anaplasia, Angiogenesis inhibitors, Pigment epithelium-derived factor, Wilms' tumor, Xenograft",
author = "Abramson, {Lisa P.} and Veronica Stellmach and Doll, {Jennifer A.} and Mona Cornwell and Arensman, {Robert M.} and Crawford, {Susan E.} and Henri Ford",
year = "2003",
month = "3",
day = "1",
doi = "10.1053/jpsu.2003.50104",
language = "English (US)",
volume = "38",
pages = "336--342",
journal = "Journal of Pediatric Surgery",
issn = "0022-3468",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model

AU - Abramson, Lisa P.

AU - Stellmach, Veronica

AU - Doll, Jennifer A.

AU - Cornwell, Mona

AU - Arensman, Robert M.

AU - Crawford, Susan E.

AU - Ford, Henri

PY - 2003/3/1

Y1 - 2003/3/1

N2 - Background/Purpose: Pigment epithelium-derived factor (PEDF), a potent endogenous inhibitor of angiogenesis, is highly expressed in the kidney. The authors postulated that systemic administration of PEDF would decrease Wilms' tumor growth in a xenograft model, and increased renal vascularity would result in a mouse null for PEDF. Methods: Tumors were induced in athymic mice using human anaplastic Wilms' tumor cells. Purified PEDF protein or vehicle was administered for 7 days beginning 2 to 3 weeks after inoculation. Tumors were stained with anti-PEDF and anti-Factor VIII antibodies. Mitoses and microvascular density (MVD) were counted per high-power field (hpf). PEDF-null mice were generated on a SV129/C57BI6 background. Wild-type and null kidneys were assessed for MVD. Results: Mean tumor weight in the 2-week group was 60% less than controls (P < .05). The MVD and mitotic count in treated tumors were significantly less than controls (P < .05). PEDF stained strongly in normal kidneys but was minimal to absent in Wilms' tumor. PEDF-null kidneys had increased MVD compared with wild-type (P < .05). Conclusions: PEDF is expressed strongly in normal murine kidney, and loss of its angioinhibitory activity may contribute to pathologic angiogenesis in Wilms' tumor. Systemic PEDF suppresses WT growth by targeting both the tumor cells and its associated vasculature.

AB - Background/Purpose: Pigment epithelium-derived factor (PEDF), a potent endogenous inhibitor of angiogenesis, is highly expressed in the kidney. The authors postulated that systemic administration of PEDF would decrease Wilms' tumor growth in a xenograft model, and increased renal vascularity would result in a mouse null for PEDF. Methods: Tumors were induced in athymic mice using human anaplastic Wilms' tumor cells. Purified PEDF protein or vehicle was administered for 7 days beginning 2 to 3 weeks after inoculation. Tumors were stained with anti-PEDF and anti-Factor VIII antibodies. Mitoses and microvascular density (MVD) were counted per high-power field (hpf). PEDF-null mice were generated on a SV129/C57BI6 background. Wild-type and null kidneys were assessed for MVD. Results: Mean tumor weight in the 2-week group was 60% less than controls (P < .05). The MVD and mitotic count in treated tumors were significantly less than controls (P < .05). PEDF stained strongly in normal kidneys but was minimal to absent in Wilms' tumor. PEDF-null kidneys had increased MVD compared with wild-type (P < .05). Conclusions: PEDF is expressed strongly in normal murine kidney, and loss of its angioinhibitory activity may contribute to pathologic angiogenesis in Wilms' tumor. Systemic PEDF suppresses WT growth by targeting both the tumor cells and its associated vasculature.

KW - Anaplasia

KW - Angiogenesis inhibitors

KW - Pigment epithelium-derived factor

KW - Wilms' tumor

KW - Xenograft

UR - http://www.scopus.com/inward/record.url?scp=0037371954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037371954&partnerID=8YFLogxK

U2 - 10.1053/jpsu.2003.50104

DO - 10.1053/jpsu.2003.50104

M3 - Article

VL - 38

SP - 336

EP - 342

JO - Journal of Pediatric Surgery

JF - Journal of Pediatric Surgery

SN - 0022-3468

IS - 3

ER -